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Abstract
Background:  Blood group genotyping is increasingly utilized for prenatal diagnosis and after
recent transfusions, but still lacks the specificity of serology. In whites, the presence of antigen D
is predicted, if two or more properly selected RHD-specific polymorphism are detected. This
prediction must fail, if an antigen D negative RHD positive allele is encountered. Excluding RHDψ
and CdeS frequent only in individuals of African descent, most of these alleles are unknown and the
population frequency of any such allele has not been determined.
Methods:  We screened 8,442 antigen D negative blood donations by RHD PCR-SSP. RHD PCR
positive samples were further characterized by RHD exon specific PCR-SSP or sequencing. The
phenotype of the identified alleles was checked and their frequencies in Germans were determined.
Results:  We detected 50 RHD positive samples. Fifteen samples harbored one of three new Del
alleles. Thirty samples were due to 14 different D negative alleles, only 5 of which were previously
known. Nine of the 14 alleles may have been generated by gene conversion in cis, for which we
proposed a mechanism triggered by hairpin formation of chromosomal DNA. The cumulative
population frequency of the 14 D negative alleles was 1:1,500. Five samples represented a D+/-
chimera, a weak D and three partial D, which had been missed by routine serology; two recipients
transfused with blood of the D+/- chimera donor became anti-D immunized.
Conclusion:  The results of this study allowed to devise an improved RHD genotyping strategy,
the false-positive rate of which was lower than 1:10,000. The number of characterized RHD positive
antigen D negative and Del alleles was more than doubled and their population frequencies in
Europe were defined.
Introduction
The antigen D encoded by the RHD gene is the most im-
portant blood group antigen determined by a protein.
About 15% of whites are antigen D negative. Antigen D
prediction by PCR was initially applied to fetus at risk for
hemolytic disease of the newbom [1,2]. If serologic blood
group typing cannot be performed with its usual ease, an
RHD genotyping with a specificity and sensitivity com-
parable to serologic methods is of practical importance.
For example, the utility of blood group genotyping in pa-
tients with recent transfusions was demonstrated by sev-
eral studies [3,4,5,6].
The two RH genes, RHD and RHCE are about 30,000 bp
apart [7], have opposite orientation [7,8] and are homol-
ogous retaining more than 90% identity [9]. The most
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frequent cause for the absence of the antigen D in whites
is the lack of the whole RHD gene [10] due to a deletion
occurring in the Rhesus box [7]. Therefore, most meth-
ods for antigen D prediction in whites probed the pres-
ence of RHD specific polymorphism [1,2,11,12,13]. Two
RHD positive antigen D negative alleles are frequent in
Africans: RHDψ  carries a 37 bp insertion at the intron 3/
exon 4 boundary and also harbors a stop codon [14]; Cde
s is a RHD-CE-D hybrid gene [15,16,17]. In Asians, a ma-
jor allele may be associated with a G314V missense mu-
tation [18], and several other alleles may represent RHD-
CE-D hybrid alleles [18,19,20].
In whites, RHD positive antigen D negative alleles were
considered rare. However, the single systematic study
[21] indicated a frequency of up to 22% among the rare
haplotype  Cde, which would render them the major
cause of false-positive antigen D prediction by PCR in
whites. The majority of RHD positive alleles in D nega-
tives were reported as scattered case reports
[22,23,24,25,26,27] with an often incomplete molecular
work-up. The relative frequencies of these alleles and
their cumulative population frequency remained un-
known.
The specificity of RHD genotyping can be improved by a
systematic characterization of RHD positive antigen D
negative alleles. This rationale prompted us to determine
the molecular causes of such alleles and their population
frequencies in a random survey among European blood
bank donors. We screened more than 8,000 antigen D
negative blood donations by RHD PCR, including more
than 700 rare Ccddee or ccddEe samples. Nine RHD-CE-
D hybrid alleles, 5 other D negative and 3 Del alleles were
identified. Five D positive donors missed by routine se-
rology were uncovered. Two anti-D immunizations were
traced. We established frequency estimates for RHD
positive antigen D negative haplotypes in whites, which
allowed us to devise an optimized RHD PCR strategy
with an enhanced and defined specificity.
Results
Population surveys
In a first survey, we investigated 1,068 samples of blood
donors that were documented as antigen D negative ac-
cording to routine serologic methods. To cover the whole
length of the RHD gene, we tested the RHD promoter, in-
tron 4, exon 7, and the 3' untranslated region of exon 10
by PCR-SSP (Table 1). As antigen D negative RHD gene
positive alleles are known to preferentially occur in the
Cde and cdE haplotypes [21,22,25], we tested 754 sam-
ples with antigen C or antigen E or both along with 314
ccddee samples. We detected 48 donors who carried the
RHD gene. All were positive for antigen C or antigen E or
both (Table 1).
In a subsequent survey, we checked 7,374 ccddee sam-
ples, which were tested in pools of twenty samples for
RHD promoter, intron 4 and exon 10. This survey aimed
to increase the power of our study for ccddee donors,
which represent 92% of all antigen D negative [28]. Two
RHD positive donors were detected (Table 1). In summa-
ry, 50 RHD positive donors were found in the two popu-
lation surveys. They were further characterized by a
detailed molecular work-up including RHD exon specific
PCR-SSP, PCR of intron polymorphism or nucleotide se-
quencing.
Table 1: Population surveys of D negative blood donors documented D negative and screened by RHD PCR-SSP
Samples (n)
Documented phenotype screened PCR-SSP positive D positive*
Testing as single samples †
Ccddee 433 34 0
ccddEe 271 5 2
CCddee 24 4 0
CcddEe 19 4 2
ccddEE 6 1 0
CcddEE 1 0 0
ccddee 314 0 0
Testing as pools of 20 samples ‡
ccddee 7,374 2 1
Total 50 5
*Samples uncovered on further analysis as weak D, partial D or D+/- chimera. † Positive for at least one of four RHD specific polymorphism tested 
(promoter, intron 4, exon 7 and 3' UTR). ‡Positive for at least one of three RHD specific polymorphism tested (promoter, intron 4, and 3' UTR).BMC Genetics (2001) 2:10 http://www.biomedcentral.com/1471-2156/2/10
Exclusion of five antigen D positive donors
The molecular and serologic work-up revealed that 5 do-
nors, previously documented as antigen D negative, were
weakly antigen D positive (Table 1). Two donors of phe-
notype CcDEe carried D category VI type I and weak D
type 2, respectively. Two donors of phenotype ccDEe
carried D category VI type I and the new partial D DIM
[29], respectively. One donor of phenotype ccDee was a
D+/- chimera.
Molecular analysis of 45 antigen D negative RHD gene 
positive samples
The remaining 45 samples were investigated by RHD
exon specific PCR for exons 3, 4, 5, 6, 7, and 9. Samples
with discrepant results for RHD promoter and exon 3
were investigated for intron 1 and intron 2, those with
discrepant results for exon 7 and 9 were investigated for
intron 7 and intron 8, and those with discrepant results
for exon 9 and exon 10 were investigated for intron 9. 24
samples could be assigned to one of nine distinct RHD
PCR patterns and 21 samples were positive for all RHD
specific polymorphism investigated (Fig. 1). (i) Hybrid
alleles. The RHD PCR patterns could be explained by
nine  RHD-CE-D hybrid alleles (Fig. 1A). Only two of
these alleles could be definitively related to prior descrip-
tions of RHD positive antigen D negative alleles: One of
the three carriers of the RHD-CE(8-9)-D allele was a do-
nor previously communicated by us as "CCDnex ee", who
was negative in an RHD exon 9 PCR [27]. Another pat-
tern was identified as Cde s (Fig. 2 to Fig. 4). We cannot
exclude the possibility that some of the seven remaining
alleles have been observed previously [18,19,20,21,22,
24,25,26]. Because of the limited published data for
those observations, we found more than one "compati-
ble" allele in our study for each previous observation. It
should be noted that the hybrid structure was predicted
from the PCR pattern and alternative explanations like
combinations of two hybrid genes or partial deletions of
the RHD gene were not formally excluded, (ii) Other
alleles. The twenty-one samples positive for the nine
RHD specific polymorphism tested were assigned to one
of eight different RHD alleles (Fig. 1B). One allele was
identical with RHDψ  [14], the other seven alleles were
novel. Each allele was characterized by nucleotide se-
quencing of the ten RHD exons in at least one sample.
Once a new allele was characterized, the remaining sam-
ples were assigned by nucleotide sequencing of the in-
formative exons (Fig. 1B).
Del phenotype
Del is defined by expressing trace amounts of antigen D
that can be detected by an adsorption/elution study only
[30]. Because current routine serology cannot discrimi-
nate D negative from the Del phenotype, at least one RBC
sample of each allele (Fig. 1) was tested by adsorption
and elution. Three alleles represented the Del phenotype
(Fig. 1B) and were characterized by one missense and
two splice site mutations, respectively. For each allele,
only a single sample was sequenced, and the influence of
the mutations on mRNA splicing was not verified by
cDNA analysis. Because lack of material, we could not
formally exclude the Del phenotype for the two RHD-
CE(2-7)-D 1 samples (Fig. 1A). However, a Del expressed
by this allele was very unlikely, as several other hybrid al-
leles carrying smaller gene conversions, like RHD-CE(2-
7)-D 2, were unequivocally D negative.
Population frequencies
The population frequencies of the alleles were calculated
(Table 2). The cumulative frequency of all antigen D neg-
ative RHD gene positive haplotypes was estimated to be
1:1,537. The most frequent allele was RHD-CE(2-9)-D 2
with a frequency of 1:5,682, representing about 27% of
antigen D negative RHD gene positive alleles. Hybrid al-
leles lacking RHD exon 4 to exon 7 accounted for 68% of
antigen D negative RHD gene positive alleles. 84% of an-
tigen D negative RHD positive haplotypes carried the an-
tigen C, compared to less than 3% of all D negative
haplotypes [28]. The cumulative allele frequency of Del
was 1:3,030.
Analysis of SCARF samples
We obtained 2 ccddEE, 1 CcddEe and 1 ccddee (G+) DNA
samples through the SCARF Exchange and tested them
for promoter, intron 4, exon 7 and the 3' untranslated re-
gion by RHD PCR-SSP. Positive reactions were obtained
with the CcddEe sample only, which was assigned to the
RHD-CE(8-9)-D allele by RHD exon-specific PCR-SSP.
Optimized RHD PCR
Based on the population frequencies, we calculated the
expected positive predictive values of a positive result for
different RHD PCR strategies (Table 3). RHD PCR based
on intron 4 and exon 7 had a considerably higher positive
predictive value than testing exon 10 alone. Testing for
RHDψ  [14] improved specificity. Even greater improve-
ments were effected by testing for other allele like RHD-
CE(8-9)-D or RHD(W16X). An optimized PCR strategy
would comprise checking for RHD intron 4, exon 7 and
intron 7 complemented by the specific detection of
RHD(W16X) and RHDψ  Antigen prediction in the rare
samples positive for either of these alleles necessitates
complementary methods, since the allele in trans may be
D positive. The five polymorphism tested can be multi-
plexed in two PCR tubes (Fig. 5). This assay was about
twice as reliable as current exon scanning approaches
[6,26] requiring, if not multiplexed [26], up to 8 separate
PCR tubes [6].BMC Genetics (2001) 2:10 http://www.biomedcentral.com/1471-2156/2/10
Gene conversions in cis
The gene conversion of five hybrid alleles observed in
this study involved intron 2 (Fig. 1) which was utilized to
delineate the allele origin of the RHCE gene segment
found in the RHD gene. In all five haplotypes, a gene con-
version in cis was likely (Fig. 6A). We proposed that gene
conversions in cis occur during hairpin formation, which
is favored by the clustered gene arrangement (Fig. 6B).
Anti-D immunizations
A flow cytometry study of the RBC from the D+/- chimera
revealed 94% D negative RBC and an admixture of 6 % D
positive RBC (Fig. 7). This chimera was confirmed in a 3
month follow-up. The 24 year old donor was healthy and
had no twin. A look-back of this donor revealed 13 units
that had been issued as D negative. Two D negative recip-
ients were traced and available for an antibody screen,
both of whom were anti-D immunized.
Table 2: Estimated population frequencies for antigen D negative RHD positive and Del haplotypes in Europeans
Frequencies
In population Within haplotype
Allele Estimate 95% confidence interval Estimate Haplotype
D negative alleles
RHD-CE(2-9)-D 2 1:5,682 1:3,046 - 1:13,837 1:62 Cde
RHD-CE(2-9)-D 1 1:15,152 1:5,610 - 1:55,568 1:167 Cde
RHD-CE(8-9)-D 1:15,152 1:5,610 - 1:55,568 1:167 Cde
RHD-CE(4-7)-D 1 1:18,036 1:6,678 - 1:66,145 1:101 cdE
RHD-CE(2-7)-D 1 1:22,727 1:6,798 - 1:128,041 1:250 Cde
RHD-CE(2-7)-D 2 1:22,727 1:6,798 - 1:128,041 1:250 Cde
RHD(W16X) 1:22,727 1:6,798 - 1:128,041 1:250 Cde
RHDψ 1:37,431 1:7,032 - 1:733,950 1:14,748 cde
RHD-CE(4-7)-D 2 1:45,455* 1:8,539 - 1:891,266 1:500* Cde or cdE
Cde s 1:45,455 1:8,539 - 1:891,266 1:500 Cedes
RHD(G212V) 1:45,455 1:8,539 - 1:891,266 1:500 Cde
RHD(Y330X) 1:45,455 1:8,539 - 1:891,266 1:500 Cde
RHD(IVS8+1G>A) 1:45,455 1:8,539 - 1:891,266 1:500 Cde
RHCE(1-9)-D 1:54,107 1:10,164 - 1:1,060,924 1:303 cdE
associated with Cde 1:1,818 1:1,262 -1:2,711 1:20 Cde
associated with cdE 1:13,527 1:5,638 - 1:39,610 1:75 cdE
associated with cde 1:37,431 1:7,032 - 1:733,950 1:14,748 cde
Total 1:1,537 not applicable not applicable
D el alleles
RHD(M295I) 1:6,493 1:3,302 - 1:13,837 1:71 Cde
RHD(K409K)† 1:9,091 1:4,067 - 1:23,073 1:100 Cde
RHD(IVS3+1G>A) 1:15,152 1:5,610 - 1:55,568 1:167 Cde
Total 1:3,030 1:1,913 - 1:5,610 1:33 Cde
* Assuming a Cde haplotype; a cdE haplotype would result in a frequency of 1: 54,107 (95% confidence interval: 1:10,164 - 1:1,060,924; frequency 
within haplotype 1:303). † Silent mutation adjacent to an intron/exon boundary, probably affecting splicing.BMC Genetics (2001) 2:10 http://www.biomedcentral.com/1471-2156/2/10
Discussion
In a systematic population survey including more than
8,000 antigen D negative blood donations, we identified
14 different RHD positive antigen D negative and 3 dif-
ferent Del haplotypes, the majority of which were novel.
The molecular bases were alleles comprising RHD/
RHCE hybrids, stop codons, missense mutations and
splice site mutations. The cumulative frequency of RHD
gene positive antigen D negative haplotypes was about
1:1,500; that of the Del alleles was about 1:3,000. We de-
termined the specificity of antigen D prediction by PCR
and devised an optimized RHD PCR strategy with a cal-
culated positive predictive value greater than 0.9999.
Five antigen D positive samples missed by routine D typ-
ing were uncovered and two anti-D immunizations
traced.
For practical purposes, two groups of RHD alleles that do
not express antigen D can be distinguished. RHD alleles
of the first group lack some or many RHD specific poly-
morphism and usually represent RHD/CE hybrids. For
alleles of this group, a correct antigen D prediction may
be accomplished by a prudent selection of the RHD spe-
cific polymorphism utilized for RHD genotyping. RHD
alleles of the second group carry all RHD specific poly-
morphism and most often harbor point mutations. For
alleles of this group, a correct antigen D prediction ne-
cessitates the specific detection of an aberration that is
usually unique to the allele. The identification of four
new alleles in this group increased the number of known
alleles from 3 to 7 and was critical for improving RHD
genotyping.
The data of this study allowed for the first time to calcu-
late population frequencies of RHD positive antigen D
negative and Del alleles. This information was indispen-
sable to derive rational RHD typing strategies and will be
essential for establishing cost-efficient approaches. The
majority of samples belonging to the first group of D neg-
ative alleles (probable RHD/CE hybrids) was compatible
with RHD-CE-D hybrid alleles, in which the DNA seg-
ment derived from the RHCE gene encompassed at least
exon 4 to exon 7. These samples would be correctly
typed, if exon 4/intron 4 and exon 7 were used for RHD
genotyping, as proposed previously [13]. With the excep-
tion of RHD exon 9, testing additional RHD exons would
not have improved the specificity of antigen D predic-
tion. Improving this specificity, however, became possi-
ble by the specific detection of frequent alleles of the
second group, like RHDψ  and RHD(W16X). We demon-
strated that testing 5 carefully selected polymorphism
would have resulted in an assay yielding false positive re-
sults at a rate less than 1:12,000, and hence would have
doubled the specificity compared to contemporary ap-
proaches testing all informative RHD exons [6,26]. Fur-
ther improvements may be achieved by the specific
detection of additional alleles, that might become practi-
cal in massively parallel molecular assays.
The detailed analysis including intron polymorphism re-
vealed that the first group of alleles (probable RHD/CE
hybrids) represented at least 9 different molecular
events. We proposed that the proximity and inverse ori-
entation of both RH genes favored gene conversions oc-
curring in cis (Fig. 6), which have also been noted in
partial D [31]. An exact definition of the molecular bases
of the RHD/CE hybrids would allow their specific detec-
Table 3: Expected rates of false positive results and expected positive predictive values for differentRHD PCR strategies*
Rate of Positive predictive value Number of
PCR strategy false positives of positive result polymorphism tested
Exon 10 only [1,2] 1:1,276 0.999216 1
Intron 4/Exon 7 [13] 1:4,081 0.999755 2
Intron 4/Exon 7/RHDψ  [14] 1:4,700 0.999787 3
Intron 4/Exon 7/W16X 1:5,212 0.999808 3
Intron 4/Exon 7/Intron 7 1:6,051 0.999835 3
Exons 3, 4, 5, 6, 7, 9 [26] 1:6,051 0.999835 6
Exons 2, 3, 4, 5, 6, 7, 9, 10 [27] 1:6,051 0.999835 8
Intron 4/Exon 7/W16X/RHDψ 1:6,267 0.999840 4
All Exons/RHDψ 1:7,520 0.999867 9
Intron 4/Exon 7/Intron 7/W16X 1:8,921 0.999888 4
Intron 4/Exon 7/Intron 7/W16X/RHDψ 1:12,533 0.999920 5
* Rates were calculated based on the population frequencies of different alleles determined in the Table 2. The exact rates are population dependent 
and may vary according to the prevalence of alleles in the population tested.BMC Genetics (2001) 2:10 http://www.biomedcentral.com/1471-2156/2/10
tion, even if they were positioned in trans to the regular
RHD allele. Such a detection would be necessary, if mo-
lecular RH zygosity testing is expected to achieve the
same specificity as antigen D prediction.
A considerable proportion of seemingly D negative sam-
ples carrying the RHD gene presented a Del phenotype.
Interestingly, RHD(M295I) coded for weak D, if associ-
ated with a ce haplotype [32], but for Del, if associated
with a Ce haplotype; this observation may be explained
by the suppressive effect of C in cis [33].
The nature and frequency of RHD gene positive antigen
D negative alleles differ among populations. Apart from
a probably lower absolute frequency, we detected in Eu-
ropeans many parallels to oriental populations: Both
populations shared the diverse nature of RHD haplo
types of the first group (probable RHD/CE hybrids)
[18,19,20], the preferential occurrence of RHD positive
antigen D negative alleles in Cde haplotypes [18], and the
comparatively frequent observation of Del phenotypes
[19]. In contrast, RHDψ  and Cdes are predominant in
African populations [14]. Still another situation may be
present in the middle-west USA, where 6 of 26 RHD gene
positive antigen D negative samples had aberrations lim-
ited to a single exon yet detectable by PCR [34].
Blood group serologists might note the observation of 5
D positive samples in our study with disturbance. In
many centers, donors are checked for antigen D by sen-
sitive methods at first and second donations only. On
subsequent donations, carriers of partial D, like DvI or
DIM, some weak D and D+/- chimerism may pass unno-
ticed in tests based on direct agglutination, even with the
most avid IgM anti-D. Immunizations caused by units of
such donors will generally be missed, because the occur-
rence of an anti-D in a patient is usually not further in-
vestigated [35]. For example, the two anti-D
immunizations induced by units of the chimerical donor
of this study were found only in a look-back triggered by
our molecular screen. Chimeras in the Rh system have
repeatedly been observed [36,37] and chimeras may be a
more widespread phenomenon than anticipated [38]. A
lower antigen density threshold for anti-D immunization
has not been established yet, and future studies might in-
dicate a need to exclude even Del donors from transfu-
sion to D negative recipients. A routine investigation of
all samples by adsorption and elution is not feasible.
However, checking D-negative samples, especially those
occurring with a C or E or both, for RHD specific se-
quences by nucleic amplification techniques may be-
come practical in the near future. The knowledge of the
detected alleles is also important for fetal genotyping as-
says using fetal DNA in maternal plasma, because false
positive results will be obtained in mothers harboring
RHD positive D negative alleles.
Subjects and Methods
Blood samples
EDTA- or citrate-anticoagulated blood samples were col-
lected from blood donors characterized as D negative in
routine typing including an antiglobulin test with anti-D.
The D antigen determination in antiglobulin technique
was performed as part of routine blood donor typing over
a period of more than 15 years with varying commercial
anti-D in tube or column agglutination. For each donor,
this antiglobulin test was done only once, if the donor
lacked the antigens C or E, and two times from independ-
ent samples, if the donor was either C or E positive. Sub-
sequent donations were checked by direct agglutination
using an Olympus PK7200 autoanalyzer only. Samples
were collected at random for specific CcEe phenotypes.
DNA was isolated by a modified salting-out procedure as
described [27,39].
Screening by PCR with sequence specific priming (PCR-
SSP)
For the first population survey, 314 ccddee, 433 Ccddee,
271 ccddEe, 19 CcddEe, 24 CCddee, 1 CcddEE and 6 ccd-
dEE samples were tested individually for the presence of
RHD specific polymorphism located in the RHD promot-
er, intron 4, exon 7 and the 3' untranslated region of exon
10 by PCR-SSP. The donor previously reported as "CCD-
nexee" [27] returned by chance and his allele was further
characterized as RHD-CE(8-9)-D.
For the second population survey, 7,374 ccddee samples
were analyzed in pools. Equal volumes of 20 samples
were mixed. To confirm the sensitivity of the pool test-
ing, 1% of D positive blood was added to an aliquot as
positive control. DNA was extracted and checked for
RHD promoter, intron 4, and exon 10 using modified
PCR-SSP to enhance sensitivity. Repeated testing of do-
nors was minimal, because the mandatory donation in-
terval exceeded the collection period.
The donors were representative for the population cur-
rently living in the county of (Land) Baden-Württem-
berg. The ethnic origin of individual donors, in particular
of those carrying Cdes or RHDψ  was not identified. Inde-
pendent of the population surveys, 2 ccddEE, 1 CcddEe
and 1 ccddee DNA samples of unknown ethnic back-
grounds were obtained from the SCARF Exchange (Hah-
nemann University, Philadelphia, USA).
Further molecular characterization
All samples positive for any of the above mentioned
PCR-SSP assays were further investigated for the pres-
ence of RHD specific polymorphism in exon 3, exon 4,BMC Genetics (2001) 2:10 http://www.biomedcentral.com/1471-2156/2/10
Figure 1
Predicted molecular structure of the 17 RHD positive, D negative or Del alleles detected. For each haplotype, a schematic rep-
resentation of the molecular structure is shown along with a designation, haplotype association, phenotype, and numbers of
samples observed. Each RHD exon is indicated by a box, intron and promoter polymorphism investigated are shown as circles.
White symbols indicate the presence of RHD specific sequences, black symbols their lack as predicted form the RHD exon-spe-
cific PCR-SSP results. Exons 1, 2, and 8 are shown in gray, because they are identical in RHD and some RHCE alleles. Panel A:
Hybrid alleles. The molecular structures are represented as single hybrid alleles; it should be noted that the PCR patterns
could also be caused by combinations of hybrid alleles or by partial RHD deletions. Panel B: Other alleles. The nature of the
aberration is indicated, and its position visualized by a vertical bar. The RHD(M295I) allele is similar to weak D type 11 [32] but
represents a different haplotype and phenotype.
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exon 5, exon 6, exon 7, and exon 9 by PCR-SSP. Samples
positive for all PCR-SSP were sequenced, until they could
be assigned to a distinct RHD allele. Samples negative
for some PCR-SSP were checked for informative poly-
morphism in intron 1, intron 2, intron 7, intron 8, and in-
tron 9.
Analysis for Cdes and RHDψ
RHD(N152T) and RHCE(L245V) present in Cdes [16]
were checked by PCR-SSP. The 37 bp insertion present in
RHDψ  was detected by PCR-SSP. The 37 bp insertion,
the M218I, F223V and S225F missense mutations and
the Y269X nonsense mutation previously described for
RHDψ  [14] were confirmed by sequencing of all 10 ex-
ons; no additional aberrations were detected.
Nucleotide sequencing
The ten RHD exons were sequenced as described
[29,32]. The promoter was amplified with primers
rend31k (for RHD alleles) or re04 (for RHCE) and rb45
and a DNA stretch encompassing primer re012 was se-
quenced using primers re08 and re09.
RHD PCR
Most RHD PCR-SSP were similar to the RHD exon spe-
cific PCR-SSP previously described [27]. Cycling condi-
tions consisted of an initial denaturation of 2 min at
94°C, followed by ten cycles of 10 s denaturation at 94°C
and 1 min annealing/extension at 65°C; and finally 25 cy-
cles of 30 s denaturation at 94°C, 1 min annealing at 61°C
and 30 s extension at 72°C. 0.4 U Taq polymerase (Qia-
gen, Hilden, Germany) were used in a final volume of 10
µl. Primers (Table 4) were re012 and re011d for the pro-
moter; re41 and rb12 for intron 4; ga71 and ga72 for exon
7 in the PCR-SSP screening; rea7 and rr4 for exon 10;
ga31 and rb21 for exon 3; ga41 and ga42 for exon 4; rb24
and ga51 for exon 5; ga62 and ga61 for exon 6; rb26 and
re71 for exon 7 in the molecular work-up; re83 and re94
for exon 9; rb51 and rb52 for intron 7; RhPsiF and RhPs-
iB for RHDψ  ; Rh152Tb and ga31 for RHD(N152T); and
Rh223Vf and Rh245Vb for RHCE(L245V). Primer con-
centrations were 0.2 µM except for exon 6 (0.1 µM),
RHD(N152T)(0.3 µM), and intron 7 and exon 9 (both 0.4
µM). For most samples intron 4/exon 7 was tested as
multiplex reaction containing 0.2 µM of exon 7 (ga71/
ga72) and 0.1 µM of intron 4 primers. As internal control,
two primers amplifying an HGH gene fragment were
added in concentrations of 0.05 µM for promoter, intron
4, and exon 7 (ga71/ga72); 0.075 µM for exon 10; 0.1 µM
for intron 7, RHDψ , RHD(N152T) and RHCE(L245V);
0.15 µM for exon 3, exon 4, exon 7 (rb26/re71), and exon
9; 0.2 µM for exon 5 and exon 6. Mg2+ concentration was
0.15 µM, except 0.4 µM for intron 7. For exon 6, 20 % so-
lution Q (Qiagen) was added. To enhance sensitivity, the
pools were tested with RHD primers in a concentration
of 0.3 µM and HGH primers at 0.1 µM.
Intron 1 was tested 1173 and 1174 bp 5' of the intron 1/
exon 2 boundary by RHD specific amplification of exon 2
as described [32]. Intron 2 was evaluated by PCR with
Figure 2
RHD exon specific PCR-SSP of Cdes. In an RHD positive control, RHD specific PCR products are obtained for the RHD pro-
moter (lane marked P, 255 bp), exon 3 (154 bp), exon 4 (123 bp), exon 5 (228 bp), exon 6 (133 bp), exon 7 (123 bp), exon 9
(119 bp) and exon 10 (232 bp). The 434 bp control product derives from the HGH gene. In the Cdessample, RHD specific ampli-
cons are obtained for exon 3, exon 9, and exon 10, only.BMC Genetics (2001) 2:10 http://www.biomedcentral.com/1471-2156/2/10
length polymorphism as described [31]. The BamHI re-
striction site introduced by the 9 bp deletion in RHD in-
tron 8 position 1114 to 1122 (Genbank accession number
AL139426) was checked after amplification with primers
re74 and re93 and digestion with BamHI. The 980 bp de-
letion starting at position 633 in RHD intron 9 (Genbank
accession number AL139426) was evaluated using prim-
ers re93k and re916.
Optimized RHD PCR-SSP for routine DNA typing
Reaction A contained primers ga71 and ga72 at 0.3 µM,
rb12 and re41 at 0.1 µM, and HGH primers at 0.1 µM.
Mg2+ was at 0.175 µM. Reaction B contained primers
RhPsiF and RhPsiB at 0.5 µM, re11d and RhX1f1 at 0.3
µM, re721 and rb9 at 0.2 µM and as control primers
rend9b1 and rend9b2 at 0.2 µM. Mg2+ was at 0.15 µM.
Immunohematology
One sample of each RHD positive allele was evaluated by
direct agglutination with two monoclonal anti-D (Sera-
clone anti-D, clone BS226; Biotest, Dreieich, Germany;
and Frekaklon anti-D, clone MS201; Gull, Bad Homburg,
Germany). Indirect antiglobulin test was done in a gel
matrix test (LISS-Coombs 37°C, DiaMed-ID Micro Typ-
ing System, DiaMed, Cressier sur Morat, Switzerland)
using an oligoclonal anti-D (Seraclone anti-D blend,
clones H41 11B7, BS221 and BS232; Biotest). Samples re-
active in gel matrix technique were further investigated
using the monoclonal anti-D HM10, HM16, P3x61,
P3x35, P3x212 11F1, P3x212 23B10, P3x241, P3x249,
P3x290 (Diagast, Loos, France) and H41 11B7 (Biotest).
The presence of a Del phenotype was determined by ad-
sorption of 500 µl of a polyclonal anti-D (human incom-
plete anti-D; Lorne Laboratories, Reading, UK) to 500 µl
packed red blood cells (RBC) for 1 h at 37°C and elution
using a chloroform technique [35]. A detailed serologic
report of the RHD(C285Y) sample, dubbed DIM [29],
has been published separately.
Flow cytometry
Flow cytometry was performed as described [40,41] us-
ing a polyclonal anti-D (anti-D Molter; Ortho Clinical Di-
agnostics, Neckarsgmünd, Germany) as primary and
goat anti-human IgG, Fab-fragment, FITC-conjugated
Figure 3
Demonstration of the RHCE(L245V) and RHD(N152T) substitutions characteristic of Cdes. PCR-SSP were performed to detect
single nucleotide polymorphism characteristic for Cdes [16] and indicative of RHCE(L245V) (lanes 1 to 4, 110 bp specific prod-
uct) and RHD(N152T) (lanes 5 to 8, 120 bp specific product). Both polymorphism were present in the Cdes sample as expected
(lanes 1 and 5). The RHD-CE(4-7)-D 2 sample was compatible with Cdes according to the RHD exon specific PCR (Fig. 1) but
lacked both polymorphism (lanes 2 and 6). Negative controls were standard RHD (lanes 3 and 7), positive controls weak D
type 4 (lane 4) and DIII type IV (lane 8), respectively.BMC Genetics (2001) 2:10 http://www.biomedcentral.com/1471-2156/2/10
Figure 4
Molecular cause of the negative RHD promoter PCR in Cdes. The nucleotide sequence of the Cdes , RHD and RHCE promoter
reaching from about 1550 to 901 bp 5' of the A of the start codon is shown. The positions of the RHD specific primers re011d
and re012 used for the RHD promoter PCR are given. Nucleotides indicating RHD or RHCE origin of the Cdes sequence are
highlighted. The Cdes promoter sequence represents RHD. A small DNA stretch of at least 13 bp in the region of re012 is
replaced by the corresponding sequence of RHCE. This gene conversion caused the negative result obtained in the RHD pro-
moter PCR-SSP (Fig. 2). RHCE nucleotide sequence is according to GenBank accession number AL031284.
-1539 CCTGCATATGTTCAGAACCATCATATTGGTAGCAAGTTTCATGTCCTGTA -1490 RHD
-1546 CCTGCATATGTTCAGAACCATCATATTGGTAGCAAGTTTCATGTCCTGTA -1497 Cde
s
-1550 CCTGCATATGTTCAGAACCATCATATTGGTAGCAAGTTTCATGTCCTGCA -1501 RHCE
-1489 GTTTTCTTAACCAACCCCCTGCTAGTGGACATTTAGGTTAGTCTCAGTTT -1440 RHD
-1496 GTTTTCTTAACCAACCCCCTGCTAGTGGACATTTAGGTTAGTCTCAGTTT -1447 Cde
s
-1500 GTTTTCTTAACCAACCCCCTGCTAGCGGACATTTAGGTTAGTCTCAGTTT -1451 RHCE
-1439 TTTCCTTCTGTAAATAAAGCTGCACTGAGCAAGAAGTGACTGATGCCAAG -1390 RHD
-1446 TTTCCTTCTGTAAATAAAGCTGCACTGAGCAAGAAGTGACTGATGCCAAG -1397 Cde
s
-1450 TTTCCTTCTGTAAATAAAGCTGCACTGAGCAAGAAGTGACCGATGCCAAG -1401 RHCE
-1389 TGACTAGATGACCTTAGGTATGACCTCTCTGGGTCTTGGTTTCTTGGTCT -1340 RHD
-1396 TGACTAGATGACCTTAGGTATGACCTCTCTGGGTCTTGGTTTCTTGGTCT -1347 Cde
s
-1400 TGACTAGATGACCTTAGGTATGACCTCTCTGGGTCTTGGTTTCTTGGTCT -1351 RHCE
-1339 AAAAACAAAATGACAGGATTCGACTGGGTGATTAAAATCTCCTCTGATCT -1290 RHD
-1346 AAAAACAAAATGACAGGATTCGACTGGGTGATTAAAATCTCCTCTGATCT -1297 Cde
s
-1350 AAAAACAAAATGACAGGATTCGACTGGGTGATTAAAATCTCCTCTGATCT -1301 RHCE
-1289 ACATAGGAATTGTTTTCAAGACATTTCTGCATTCCTCTAGTGACAGGGTG -1240 RHD
-1296 ACATAGGAATTGTTTTCAAGACATTTCTGCATTCCTCTAGTGACAGGGTG -1247 Cde
s
-1300 ACATAGGAATTGTTTTCAAGACATTTCTGCATTCCTCTAGTGACAGGGTG -1251 RHCE
-1239 CTCACTACCTCATGAGTATTTCAGTGGACAACTGTAATGGTCAATAAAGT -1190 RHD
-1246 CTCACTACCTCATGAGTATTTCAGTGGACAACTGTAATGGTCAATAAAGT -1197 Cde
s
-1250 CTCACTACCTCATGAGTATTTCAGTGGACAACTGTAATGGTCAATAAAGT -1201 RHCE
----re012----- ----->
-1189 ATCCACTTTCCACCT-------CCCTGCAGCTCCTGGCCCTGGCTTTATT -1147 RHD
-1196 ATCCACTTTCCACCTTCCACTTCCCTGTAGCTCCTGGCCCTGGCTTTATT -1147 Cde
s
-1200 ATCCACTTTCCACCTTCCACTTCCCTGTAGCTCCTGGCCCTGGCTTTATT -1151 RHCE
-1146 CTCTGGGGCTCCACACATTCAGTTTACACTCAGTGGCCAGTGGCTGGGAC -1097 RHD
-1146 CTCTGGGGCTCCACACATTCAGTTTACACTCAGTGGCCAGTGGCTGGGAC -1097 Cde
s
-1150 CTCTGGGGCTCCACACATTCAGTTTACACTCAGTGGCCAGTGGCTGGGGC -1101 RHCE
-1096 CATTGTAGAAAATAAGGAAACTCCAATTCCTTCCTTCTTTTCTTCCTCTT -1047 RHD
-1096 CATTGTAGAAAATAAGGAAACTCCAATTCCTTCCTTCTTTTCTTCCTCTT -1047 Cde
s
-1100 CATTGTAGAAAATGAGGAAACTCCAATTCCTTCCTTCTTTTCTTCCTCTT -1051 RHCE
-1046 TCATCTCTTCCTCCCTCTCTACATCCCTCTCTCTCTTCCTTCCTTCCTCG -997 RHD
-1046 TCATCTCTTCCTCCCTCTCTACATCCCTCTCTCTCTTCCTTCCTTCCTCG -997 Cde
s
-1050 TCATCCCTTCCTCCCTCCCTACATCCCTCTCTCTCTTCCTTCCTTCCTTG -1001 RHCE
<----
-996 ACACTTACCATGTACCAGACCTTCTGCCAGGCACATGGATGGGAGCACAG -947 RHD
-996 ACACTTACCATGTACCAGACCTTCTGCCAGGCACATGGATGGGAGCACAG -947 RHD
-1000 ACACTTACCATGTACCAGACCTTCTGCCAGGCACATGGATGGGAGCACAG -951 RHD
--re011d------
-946 ----GGGAAGTTGGCTGCAGGGTTAGAACTAAGTCCCAAGCCCCCTAAAG -901 RHD
-946 ----GGGAAGTTGGCTGCAGGGTTAGAACTAAGTCCCAAGCCCCCTAAAG -901 Cde
s
-950 TTCCGGGAAGTTGGCTGCAGGGTTAGAACTAAGTCCCAAGCCCCGTAAAG -901 RHCEBMC Genetics (2001) 2:10 http://www.biomedcentral.com/1471-2156/2/10
(Dianova, Hamburg, Germany) as secondary antibody.
Markers were set to encompass >99.5% of a D positive
control and less than 0.5% of a D negative control. The
percentage of cells in the marker area was evaluated.
Haplotype frequencies
For alleles observed more than once, the haplotype asso-
ciation with Cde and cdE was obvious, because of their
repeated observations in association with the rare phe-
notypes Ccddee or ccddEe, respectively. Based on the
paucity of RHD positive samples among the ccddee sam-
ples, alleles that were observed only once were assumed
to be associated with the Cde or cdE haplotype rather
than the cde haplotype. An allele occurring in an unique
CcddEe sample was counted as Cde. The RHDψ  allele
was assumed to be associated with the ce(W16C) allele,
because RHCE specific sequencing of exon 1 revealed a
C/G heterozygosity at position 64 and ce(W16C) is al-
most absent from the cde haplotypes in our population
[27]. The frequency of a given aberrant RHD allele in its
haplotype was calculated as the number of observed
samples divided by the number of the corresponding
haplotypes under observation (500 Cde, 303 cdE). For
cde, the haplotype frequency was calculated from the
14,748 haplotypes checked in the second survey. The
population frequency of an RHD allele was calculated
from the frequency of this allele in its haplotype and the
known frequency of the haplotype in the local population
[28]. Confidence intervals were calculated according to
the Poisson distribution [42]. Donors were not generally
Figure 5
RHD PCR-SSP optimized for specificity. The PCR is performed as a modular system consisting of two multiplex reactions. An
RHD intron 4/exon 7 multiplex PCR-SSP (Panel A) is combined with an RHD intron 7 PCR that is multiplexed with reactions
for the specific detection of RHD(W16X) and RHDψ  (Panel B). Results are shown for a normal D positive sample (lane 1), a
normal D negative sample (lane 2), several rare D negative samples (lanes 3 to 6) and major D positive RHD variants (lanes 7
and 8). Standard D positive and D negative samples and D categories VI and IV are recognized in panel A. RHD-CE(8-9)-D is
detected in panel B by the absence of the intron 7 band (lane 3). The presence of RHD(W16X) and RHDψ  is detected in panel
B because of their specific amplicons (lanes 4 and 5). Amplicon size is Panel A, control, 434 bp (HGH gene); intron 4, 226 bp;
exon 7, 123 bp; Panel B, control, 659 bp (chromosome 1 genomic sequence about 90,000 bp 5' of Rhesus box); intron 7, 390 bp;
RHD(W16X), 248 bp; RHDψ , 154 bp. The internal control amplicons, which were devised to be larger than the specific ampli-
cons, may be suppressed because of competition, if a specific product is amplified.BMC Genetics (2001) 2:10 http://www.biomedcentral.com/1471-2156/2/10
Figure 6
Gene conversion in cis. Panel A: Origin of the RHCE gene segments. The allele origin of the RHCE segments in the RHD gene
was analyzed by a PCR length polymorphism in intron 2 [31,43]. The 1,177 bp product is specific for the C allele of RHCE, the
1,068 bp product for the c allele of RHCE and for RHD. The CcDee control shows a strong band at the c/D position and a
weaker band at the C position (lane 1). The cE associated RHCE(1-9)-D hybrid allele lacks the C band (lane 2), indicating that
the intron 2 of the hybrid allele derives from c. In contrast, all Ce associated hybrid alleles involving intron 2 show a strong C
band and a weaker c/D band (lanes 3 to 6), indicating that the introns 2 of those hybrids derive from C. Panel B: Proposed
mechanism of gene conversion in cis. (i) The RHD and RHCE genes are inversely orientated [7] as typical for clustered genes. (ii)
A putative hairpin formation of the chromosome allows the close proximity of homologous segments in identical orientation.
This structural feature is instrumental for gene conversion events in cis. (iii) Resolving the hairpin yields an RHD-CE-D hybrid
gene structure, many of which have been observed to date at the RH gene locus. As an example, the RHD-CE(4-7)-D hybrid
exon structure is shown. Symbols are according to Fig. 1.
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checked for kinship. However, the three RHD-CE(8-9)-
D donors were siblings; a fourth sample was independ-
ently observed in the single RHD positive DNA from the
SCARF Exchange.
Table 4: Primers used
Genomic
Name Nucleotide sequence region Position* Strandedness specificity
ga31 ttgtcggtgctgatctcagtgga exon 3 362 to 383 sense RHD
ga41 acatgatgcacatctacgtgttcgc exon 4 503 to 527 sense RHD/RHCE
ga42 cagacaaactgggtatcgttgctg exon 4 625 to 602 antisense RHD/RHCE
ga51 ctgctcaccttgctgatcttccc intron 5/exon. 5 8 to 787 antisense RHD
ga61 caggtacttggctcccccgac exon 6 936 to 916 antisense RHD
ga62 ttatgtgcacagtgcggtgttgg exon 6 804 to 826 sense RHD/RHCE
ga71 gttgtaaccgagtgctggggattc exon 7 944 to 967 sense RHD/RHCE
ga72 tgccggctccgacggtatc exon 7 1066 to 1048 antisense RHD
rb12 tcctgaacctgctctgtgaagtgc intron 4 198 to 175 antisense RHD
rb21 aggtccctcctccagcac intron 3 28 to 11 antisense RHD/RHCE
rb24 agacctttggagcaggagtg intron 4 -53 to -34 sense RHD/RHCE
rb26 aggggtgggtagggaatatg intron 6 -62 to -43 sense RHD/RHCE
rb45 acactgttgrctgaatttcggtgc intron 1 164 to 139 antisense RHD/RHCE
rb51 gcatgacgtgttctgcctcttg intron 7 -3365 to - 3386 antisense RHD
rb52 ccaggttgttaagcattgctgtacc intron 7 -3433 to -3409 sense RHD
re04 aggtcacatccatttatcccactg promoter -2498 to -2474 sense RHD/RHCE
re08 gggcttgggacttagttctaac promoter -858 to -879 antisense RHD/RHCE
re09 cgactgggtgattaaaatctcc promoter -1280to-1259 sense RHD/RHCE
re011d gcagccaacttcccctgtg promoter -883 to -905 antisense RHD
re012 tccactttccacctccctgc promoter -1148to-1122 sense RHD
relld agaagatgggggaatctttttcct intron 1 129 to 106 antisense RHD/RHCE
re41 cgatacccagtttgtctgccatgc exon 4 608 to 631 sense RHD/RHCE
re71 acccagcaagctgaagttgtagcc exon 7 1,008 to 985 antisense RHD
re74 tatccatgaggtgctgggaac intron 7 -244 to -224 sense RHD/RHCE
re721 ctggaggctctgagaggttgag intron 7 -348 to -326 sense RHD
re83 gagattaaaaatcctgtgctcca intron 8 -54 to - 34 sense RHD/RHCE
re93 cacccgcatgtcagactatttggc intron 9 320 to 297 antisense RHD/RHCE
re93k gccaaatagtttgacatgcgggtg intron 9 297 to 320 sense RHD/RHCE
re94 cttggtcatcaaaatatttagcct exon 9 1216 to 1193 antisense RHD
re916 gtttttgaggcaaagtctcgctc intron 9 1689 to 1666 antisense RHD/RHCE
rea7 tgttgcctgcatttgtacgtgag 3' UTR† 1311 to 1333 sense RHD/RHCE
rend31k cctccccaacccagacagaattag AJ252311‡ 8506 to 8529 sense not applicable
rend9b1 cactgcacttggcaccattgag AL031432 29489 to 29468 antisense not applicable
rend9b2 ttccgaaggctgcttttccc AL031432 28840 to 28859 sense not applicable
Rh152Tb gatattactgatgaccatcctcatgg exon3 480 to 455 antisense RHCE
Rh223Vf ttgtggatgttctggccaagtg exon 5 646 to 667 sense RHCE
Rh245Vb gctgtcaccactctgactgctac exon5 755 to 733 antisense RHD
RhPsiB tctgatctttatcctccgttccctc exon 4 601 to 577 antisense RHD
RhPsiF agacagactaccacatgaacttac intron 3 -38 to-15 sense RHDψ
RhX1f1 cgctgcctgcccctctga exon 1 31 to 48 sense RHD(W16X)
rr4 agcttactggatgaccacca 3'UTR 1,541 to 1,522 antisense RHD
*The positions of the synthetic oligonucleotides are indicated relative to their distances from the first nucleotide position of the start codon ATG 
for all primers in the promoter and in the exons including the 3' untranslated part of exon 10, relative to their adjacent exon/intron boundaries of 
RHCE for primers in introns; and according to the numbering in the genomic sequences indicated. Primers rh1 [44], ga31 (previously dubbed D-3-
383), ga41 (D-4-527), ga42 (D-4-602), ga51 (D-5-787), ga61 (D-6-916), ga62 (D-6-826), ga71 (D-7-967), ga72 (D-7-1048) [27], rb5, rb12, rb24, rh5, 
rh7 [31], rb21, rb26, re11d, re71, re74, re83, re93, rr4 [32], re012 [29], re011d and rea7 [7] have been published previously. † 5' UTR: 5' untranslated 
region of exon 1; 3' UTR: 3' untranslated region of exon 10. ‡ Accession number of nucleic acid sequence in EMBL/GenBank/DDBJ; AJ252311 rep-
resents upstream Rhesus box; AL031431 Chromosome 1 genomic clone dJ465N24.BMC Genetics (2001) 2:10 http://www.biomedcentral.com/1471-2156/2/10
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